PURIFICATION OF AN ESCHERICHIA-COLI-EXPRESSED NEF PROTEIN FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2

被引:3
|
作者
DUBOIS, GC
HODGE, DR
HANSON, CA
SAMUEL, KP
ZWEIG, M
SHOWALTER, SD
PAPAS, TS
机构
[1] NCI,FREDERICK CANC RES & DEV CTR,NUCLEIC ACID & PROTEIN SYNTHESIS LAB,FREDERICK,MD 21701
[2] NCI,FREDERICK CANC RES & DEV CTR,MOLEC ONCOL LAB,FREDERICK,MD 21701
关键词
D O I
10.1089/aid.1993.9.1225
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The entire nef gene sequence of HIV-2, NIH-Z strain, has been cloned into the pJL6 expression vector and used for the synthesis of a 23-kDa protein in E. coli. The expressed protein is a fusion between the N-terminal 13 amino acids of the cII gene, 8 amino acids resulting from the ligation procedure, and the 180 amino acids that comprise the HIV-2 Nef sequence from the NIH-Z strain. The bacterially expressed Nef protein has been purified to apparent homogeneity on analytical scale (10-20 mug) by a combination of sequential detergent extraction, gel filtration, and reversed-phase high-performance chromatography. The expressed Nef protein is highly susceptible to proteolysis (chymotryptic-like activity) and this property accounts for the low yield obtained by gel filtration and RP-HPLC. Larger amounts (>100 mug) of the purified Nef protein have been produced by a purification procedure that employs sequential detergent extraction, chromatography on Q-Sepharose in the presence of 7 M urea, and chromatography on hydroxylapatite, also in 7 M urea. The purified HIV-2 Nef protein has been used for the production of polyclonal and monoclonal antibodies. The milder method of purification should facilitate structure-function studies of the Nef protein and its role in the life cycle of HIV.
引用
收藏
页码:1225 / 1231
页数:7
相关论文
共 50 条
  • [1] HUMAN-IMMUNODEFICIENCY-VIRUS, TYPE-2
    BEKTIMIROV, TA
    [J]. VOPROSY VIRUSOLOGII, 1990, 35 (03) : 180 - 183
  • [2] Purification and characterization of the human immunodeficiency virus type 1 integrase expressed in Escherichia coli
    Oh, JW
    Shin, CG
    [J]. MOLECULES AND CELLS, 1996, 6 (01) : 96 - 100
  • [3] INFECTION WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2
    MARKOVITZ, DM
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) : 211 - 218
  • [4] THE SPECIFICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 TRANSACTIVATOR IS DIFFERENT FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    EMERMAN, M
    GUYADER, M
    MONTAGNIER, L
    BALTIMORE, D
    MUESING, MA
    [J]. EMBO JOURNAL, 1987, 6 (12): : 3755 - 3760
  • [5] MUTATIONAL ANALYSIS OF THE INTEGRASE PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2
    VANGENT, DC
    GROENEGER, AAMO
    PLASTERK, RHA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (20) : 9598 - 9602
  • [6] OLIGOMERIZATION OF THE NEF PROTEIN FROM HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1
    KIENZLE, N
    FREUND, J
    KALBITZER, HR
    MUELLERLANTZSCH, N
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (02): : 451 - 457
  • [7] PURIFICATION AND CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF GENE-PRODUCT EXPRESSED BY A RECOMBINANT BACULOVIRUS
    MATSUURA, Y
    MAEKAWA, M
    HATTORI, S
    IKEGAMI, N
    HAYASHI, A
    YAMAZAKI, S
    MORITA, C
    TAKEBE, Y
    [J]. VIROLOGY, 1991, 184 (02) : 580 - 586
  • [8] REGULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS NEF PROTEIN BY PHOSPHORYLATION
    BANDRES, JC
    LURIA, S
    RATNER, L
    [J]. VIROLOGY, 1994, 201 (01) : 157 - 161
  • [9] INFECTION BY THE TYPE-2 HUMAN-IMMUNODEFICIENCY-VIRUS IN A PROSTITUTE
    ARMENGOL, P
    VILLENA, MJ
    CABALLERO, E
    JUSTE, C
    [J]. MEDICINA CLINICA, 1995, 104 (04): : 156 - 157
  • [10] NEUROSYPHILIS AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 INFECTION
    SAVALL, R
    CABRE, M
    GRIFOL, M
    [J]. ARCHIVES OF NEUROLOGY, 1992, 49 (05) : 440 - 440